164 related articles for article (PubMed ID: 2981351)
1. Epstein-Barr virus transformation of human B lymphocytes despite inhibition of viral polymerase.
Sixbey JW; Pagano JS
J Virol; 1985 Jan; 53(1):299-301. PubMed ID: 2981351
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir inhibition of Epstein-Barr virus replication.
Datta AK; Colby BM; Shaw JE; Pagano JS
Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5163-6. PubMed ID: 6254061
[TBL] [Abstract][Full Text] [Related]
3. Copy number and location of Epstein-Barr Viral genomes in neonatal human lymphocytes transformed after separation by size and treatment with mitogens.
Anvret M; Miller G
Virology; 1981 May; 111(1):47-55. PubMed ID: 6263010
[No Abstract] [Full Text] [Related]
4. Effects of S-adenosylhomocysteine and analogs on Epstein-Barr virus-induced transformation, expression of the Epstein-Barr virus capsid antigen, and methylation of Epstein-Barr virus DNA.
Long WK; Fronko GE; Lindemeyer RG; Wu B; Henderson EE
J Virol; 1987 Jan; 61(1):221-4. PubMed ID: 3023700
[TBL] [Abstract][Full Text] [Related]
5. Effect of acyclovir [9-(2-hydroxyethoxymethyl)guanine] on Epstein-Barr virus DNA replication.
Colby BM; Shaw JE; Elion GB; Pagano JS
J Virol; 1980 May; 34(2):560-8. PubMed ID: 6246281
[TBL] [Abstract][Full Text] [Related]
6. Immortalization of human lymphocytes by Epstein-Barr virus.
Miller G
Yale J Biol Med; 1982; 55(3-4):305-10. PubMed ID: 6295007
[TBL] [Abstract][Full Text] [Related]
7. Replication of Epstein-Barr virus DNA in lymphoblastoid cells treated for extended periods with acyclovir.
Colby BM; Shaw JE; Datta AK; Pagano JS
Am J Med; 1982 Jul; 73(1A):77-81. PubMed ID: 6285738
[No Abstract] [Full Text] [Related]
8. Epstein-Barr virus gene expression during primary B-lymphocyte infection, in transformed and Burkitt lymphoma-derived cell lines.
Ernberg I; Kallin B; Dillner J
Curr Top Microbiol Immunol; 1986; 132():251-6. PubMed ID: 3024918
[No Abstract] [Full Text] [Related]
9. Activity of penciclovir against Epstein-Barr virus.
Bacon TH; Boyd MR
Antimicrob Agents Chemother; 1995 Jul; 39(7):1599-602. PubMed ID: 7492112
[TBL] [Abstract][Full Text] [Related]
10. Viral latency and transformation: the strategy of Epstein-Barr virus.
Klein G
Cell; 1989 Jul; 58(1):5-8. PubMed ID: 2546674
[No Abstract] [Full Text] [Related]
11. Regions of the EBV genome involved in latency and lymphocyte immortalization.
Miller G
Prog Med Virol; 1984; 30():107-28. PubMed ID: 6087408
[No Abstract] [Full Text] [Related]
12. Spontaneous outgrowth of Epstein-Barr virus-positive B-cell lines from circulating human B cells of different buoyant densities.
Yao QY; Czarnecka H; Rickinson AB
Int J Cancer; 1991 May; 48(2):253-7. PubMed ID: 1850387
[TBL] [Abstract][Full Text] [Related]
13. Hypomethylation of Epstein-Barr virus DNA in the nonproducer B-cell line EBR.
Larocca D; Clough W
J Virol; 1982 Sep; 43(3):1129-31. PubMed ID: 6292457
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.
Pagano JS; Datta AK
Am J Med; 1982 Jul; 73(1A):18-26. PubMed ID: 6285710
[TBL] [Abstract][Full Text] [Related]
15. Synergistic inhibition of Epstein-Barr virus: transformation of B lymphocytes by alpha and gamma interferon and by 3'-azido-3'-deoxythymidine.
Lin JC; Zhang ZX; Chou TC; Sim I; Pagano JS
J Infect Dis; 1989 Feb; 159(2):248-54. PubMed ID: 2536780
[TBL] [Abstract][Full Text] [Related]
16. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus.
Miyazaki I; Cheung RK; Dosch HM
J Exp Med; 1993 Aug; 178(2):439-47. PubMed ID: 8393476
[TBL] [Abstract][Full Text] [Related]
17. An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro.
Robertson ES; Tomkinson B; Kieff E
J Virol; 1994 Mar; 68(3):1449-58. PubMed ID: 8107208
[TBL] [Abstract][Full Text] [Related]
18. Neuramide inhibits Epstein-Barr virus-induced transformation activity and proliferation of transformed B lymphocytes.
Venanzoni MC; Angeloni A; Di Muzio M; Faggioni A; Frati L
Antiviral Res; 1997 Feb; 33(3):177-85. PubMed ID: 9037374
[TBL] [Abstract][Full Text] [Related]
19. Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus.
Thorley-Lawson DA; Strominger JL
Virology; 1978 May; 86(2):423-31. PubMed ID: 208257
[No Abstract] [Full Text] [Related]
20. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes.
Hammerschmidt W; Sugden B
Nature; 1989 Aug; 340(6232):393-7. PubMed ID: 2547164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
